athome - Lic# 14340366 | Orlando Bryant Mckee

FDA APPROVED lecanemab (Leqembi) over a computer rendering of monoclonal antibodies, amyloid plaques, and neurons.

FDA Approves At-Home Starter Dose of Alzheimer’s Drug

by Yourhealth
Medicare

The FDA approved a new starting dosage regimen for the subcutaneous formulation of lecanemab (Leqembi Iqlik) to treat adults with Alzheimer’s disease, the agency said Monday. Lecanemab is an anti-amyloid…

Equine-related injuries in rural Oklahoma: a 10-year experience emphasizing genitourinary trauma

Understanding capability, opportunity, and motivation for at-home COVID-19 testing in underserved populations during the pandemic

by Yourhealth
Resources

Abstract Background and purpose We investigated the capabilities, opportunities and motivations associated with decision making related to at-home COVID-19 testing in populations most affected by the pandemic. Methods We conducted…

Orlando Bryant Mckee

FDA Approves At-Home Starter Dose of Alzheimer’s Drug

Understanding capability, opportunity, and motivation for at-home COVID-19 testing in underserved populations during the pandemic

90% CHEAPER THAN COBRA

Compare plans from top insurers in under 3 minutes

Let’s get started!

FDA Approves At-Home Starter Dose of Alzheimer’s Drug

Understanding capability, opportunity, and motivation for at-home COVID-19 testing in underserved populations during the pandemic

Find the Perfect Health Insurance Plan for Your Needs

90% CHEAPER THAN COBRA

Compare plans from top insurers in under 3 minutes

Let’s get started!